N. Ciobanu
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immunodeficiency and Autoimmune Disorders
- T-cell and B-cell Immunology
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 3
- Cancer Treatment and Pharmacology 2
-
- Immune Cell Function and Interaction 3
- Immunotherapy and Immune Responses 3
- Co-authors
- David H. Boldt (4 shared papers)Kim Margolin (4 shared papers)Richard I. Fisher (2 shared papers)Geoffrey R. Weiss (2 shared papers)David Parkinson (1 shared paper)Stephen P. Creekmore (1 shared paper)Avi B. Markowitz (1 shared paper)Janice P. Dutcher (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)European Heart Journal (2 papers)Journal of Immunotherapy (2 papers)Antioxidants and Redox Signaling (1 paper)American Journal of Clinical Nutrition (1 paper)
- Partner nations
- United StatesMoldovaRomania
In The Last Decade
N. Ciobanu
23 papers receiving 632 citations
Peers
Comparison fields: 5 of 75
- Immunology 346
- Oncology 247
- Hematology 86
- Pathology and Forensic Medicine 89
- Genetics 40
Countries citing papers authored by N. Ciobanu
This map shows the geographic impact of N. Ciobanu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Ciobanu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Ciobanu more than expected).
Fields of papers citing papers by N. Ciobanu
This network shows the impact of papers produced by N. Ciobanu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Ciobanu. The network helps show where N. Ciobanu may publish in the future.
Co-authors
The 25 scholars most cited alongside N. Ciobanu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 180 | |
| 2 | 1983 | 94 | |
| 3 | 1984 | 77 | |
| 4 | 1992 | 67 | |
| 5 | 1990 | 66 | |
| 6 | 1991 | 25 | |
| 7 | 1991 | 21 | |
| 8 | Etoposide as an in vitro purging agent for the treatment of acute leukemias and lymphomas in conjunction with autologous bone marrow transplantation. | 1986 | 21 |
| 9 | 1993 | 20 | |
| 10 | 2020 | 20 | |
| 11 | Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study. | 1994 | 16 |
| 12 | Comparison of preparative transplantation regimens using carmustine/etoposide/cisplatin or busulfan/etoposide/cyclophosphamide in lymphoid malignancies. | 1993 | 14 |
| 13 | Malignant lymphomas, AIDS, and the pathogenic role of Epstein-Barr virus. | 1986 | 12 |
| 14 | 1983 | 10 | |
| 15 | 2022 | 10 | |
| 16 | Pilot study of high-dose mitoxantrone and busulfan plus autologous bone transplantation in patients with advanced malignancies. | 1995 | 8 |
| 17 | Reversible central nervous system toxicity associated with high-dose chlorambucil in autologous bone marrow transplantation for ovarian carcinoma. | 1987 | 4 |
| 18 | 1987 | 2 | |
| 19 | 2020 | 2 | |
| 20 | Phase i study of high dose continuous infusion interleukin 2 and autologous lymphokine activated killer cells in patients with metastatic or unresectable malignant melanoma and renal cell carcinoma | 1989 | 1 |
About N. Ciobanu
N. Ciobanu is a scholar working on Oncology, Immunology, Genetics, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine, having authored 25 papers that have together received 673 indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immune Cell Function and Interaction (3 papers), CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Immunology (346 citations), Oncology (247 citations), Hematology (86 citations), Pathology and Forensic Medicine (89 citations) and Genetics (40 citations). N. Ciobanu has collaborated with scholars based in United States, Moldova and Romania. Frequent co-authors include David H. Boldt, Kim Margolin, Richard I. Fisher, Geoffrey R. Weiss, David Parkinson, Stephen P. Creekmore, Avi B. Markowitz, Janice P. Dutcher, M Röper and Salvatore Venuta. Their work appears in journals such as Journal of Clinical Oncology, European Heart Journal, Journal of Immunotherapy, Antioxidants and Redox Signaling and American Journal of Clinical Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.